Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2010 | 2 |
2014 | 1 |
2015 | 1 |
2018 | 1 |
2019 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Page 1
Diagnosis and treatment of lipodystrophy: a step-by-step approach.
J Endocrinol Invest. 2019 Jan;42(1):61-73. doi: 10.1007/s40618-018-0887-z. Epub 2018 Apr 27.
J Endocrinol Invest. 2019.
PMID: 29704234
Free PMC article.
Review.
AIM: Lipodystrophy syndromes are rare heterogeneous disorders characterized by deficiency of adipose tissue, usually a decrease in leptin levels and, frequently, severe metabolic abnormalities including diabetes mellitus and dyslipidemia. ...Metreleptin is approved …
AIM: Lipodystrophy syndromes are rare heterogeneous disorders characterized by deficiency of adipose tissue, usually a decrease in …
Leptin treatment: facts and expectations.
Paz-Filho G, Mastronardi CA, Licinio J.
Paz-Filho G, et al.
Metabolism. 2015 Jan;64(1):146-56. doi: 10.1016/j.metabol.2014.07.014. Epub 2014 Aug 3.
Metabolism. 2015.
PMID: 25156686
Free article.
Review.
Leptin levels are undetectable or very low in patients with lipodystrophy, hypothalamic amenorrhea, and congenital leptin deficiency (CLD) due to mutations in the leptin gene. ...A better understanding of the physiological roles of leptin …
Leptin levels are undetectable or very low in patients with lipodystrophy, hypothalamic amenorrhea, and congenital leptin …
Item in Clipboard
Clinical classification and treatment of congenital and acquired lipodystrophy.
Chan JL, Oral EA.
Chan JL, et al.
Endocr Pract. 2010 Mar-Apr;16(2):310-23. doi: 10.4158/EP09154.RA.
Endocr Pract. 2010.
PMID: 20061300
Review.
OBJECTIVE: To review the initial clinical manifestations of congenital and acquired lipodystrophy syndromes, discuss novel classifications associated with genetic mutations, and assess currently available therapeutic options for patients with lipodystrophy. ...Patie …
OBJECTIVE: To review the initial clinical manifestations of congenital and acquired lipodystrophy syndromes, discuss novel classifica …
Item in Clipboard
Congenital hypogonadotropic hypogonadism in females: clinical spectrum, evaluation and genetics.
Bry-Gauillard H, Trabado S, Bouligand J, Sarfati J, Francou B, Salenave S, Chanson P, Brailly-Tabard S, Guiochon-Mantel A, Young J.
Bry-Gauillard H, et al.
Ann Endocrinol (Paris). 2010 May;71(3):158-62. doi: 10.1016/j.ando.2010.02.024. Epub 2010 Apr 3.
Ann Endocrinol (Paris). 2010.
PMID: 20363464
Review.
Congenital hypogonadotropic hypogonadisms (CHH) are a well-known cause of pubertal development failure in women. ...Some cases of mutations of FGFR1, and more rarely of its ligand FGF8, or of PROKR2 or its ligand PROK2 have been shown in women suffering from Kallmann syndr …
Congenital hypogonadotropic hypogonadisms (CHH) are a well-known cause of pubertal development failure in women. ...Some cases of mut …
Item in Clipboard
Cite
Cite